Alethio Therapeutics raises $90M for rare blood cancer drugs
The startup is developing a medicine for myeloproliferative neoplasms that an investor says could reach broader patient groups than approved drugs.
Read at Biopharmadive โFull coverage ยท 6 outlets
- Biopharmadive ยท lead
- BioPharma DiveAlethio raises $90M to target rare blood cancers
- Endpoints NewsOxford spinout Alethio clinches $90M to advance antibody for rare blood cancer
- Yahoo FinanceAlethio Therapeutics Raises $90 Million (ยฃ67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
- Health Tech WorldAlethio Therapeutics secures ยฃ67m for blood cancer treatments
- YahooAlethio raises $90M to target rare blood cancers